Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
JCO Oncology Practice
|
June 12, 2025
Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors
Michael A Liu, Rohit Raghunathan, Karie Runcie, et al.
The Prostate
|
August 6, 2010
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies
Mark Stein, Hongxia Lin, Chandrika Jeyamohan, et al.
Journal of Oncology
|
May 12, 2011
Safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-Cisplatin in patients with advanced cancer
Howard Burris, Joe Stephenson, Gregory A Otterson, et al.
Journal of Translational Medicine
|
February 25, 2010
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899
Robert S DiPaola, Yu-Hui Chen, Mark Stein, et al.
Clinical Biochemistry
|
May 2, 2002
Newborn thyroxine levels and childhood ADHD
Offie Porat Soldin, Arvind K N Nandedkar, Knoxley M Japal, et al.
Cancer
|
October 6, 2010
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
Brian I Rini, Mark Stein, Pat Shannon, et al.
Urology
|
September 17, 2015
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study
Ulka Vaishampayan, Daniel Shevrin, Mark Stein, et al.
European Urology
|
June 14, 2013
Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis
Yu-Hsuan Joni Shao, Sung Kim, Dirk F Moore, et al.
Cancer
|
November 2, 2025
Association between medication burden and acute care use in older metastatic prostate cancer patients on androgen receptor signaling inhibitors
Michael A Liu, Rohit Raghunathan, Karie Runcie, et al.
Urologic Oncology
|
July 26, 2011
Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancer
Glenn Liu, Yu-Hui Chen, Jill Kolesar, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
JCO Oncology Practice
|
June 12, 2025
Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors
Michael A Liu, Rohit Raghunathan, Karie Runcie, et al.
The Prostate
|
August 6, 2010
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies
Mark Stein, Hongxia Lin, Chandrika Jeyamohan, et al.
Journal of Oncology
|
May 12, 2011
Safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-Cisplatin in patients with advanced cancer
Howard Burris, Joe Stephenson, Gregory A Otterson, et al.
Journal of Translational Medicine
|
February 25, 2010
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899
Robert S DiPaola, Yu-Hui Chen, Mark Stein, et al.
Clinical Biochemistry
|
May 2, 2002
Newborn thyroxine levels and childhood ADHD
Offie Porat Soldin, Arvind K N Nandedkar, Knoxley M Japal, et al.
Cancer
|
October 6, 2010
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
Brian I Rini, Mark Stein, Pat Shannon, et al.
Urology
|
September 17, 2015
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study
Ulka Vaishampayan, Daniel Shevrin, Mark Stein, et al.
European Urology
|
June 14, 2013
Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis
Yu-Hsuan Joni Shao, Sung Kim, Dirk F Moore, et al.
Cancer
|
November 2, 2025
Association between medication burden and acute care use in older metastatic prostate cancer patients on androgen receptor signaling inhibitors
Michael A Liu, Rohit Raghunathan, Karie Runcie, et al.
Urologic Oncology
|
July 26, 2011
Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancer
Glenn Liu, Yu-Hui Chen, Jill Kolesar, et al.
Page
of 7